27421843|t|HIF-1α expression and high microvessel density are characteristic features in serrated colorectal cancer
27421843|a|Serrated colorectal adenocarcinoma (SAC) is a morphologically distinct subtype of colorectal cancer (CRC), in which increased HIF-1α mRNA expression and HIF-1α protein stabilization are typical features. Here we aimed to further elucidate HIF-1α protein expression in serrated and non-serrated colorectal carcinomas (CRCs) and their precursor lesions and its association with vascular endothelial growth factor (VEGF) and microvascular density (MVD). HIF-1α and VEGF expressions were determined immunohistochemically in 134 serrated polyps (SPs), 104 non-serrated adenomas (NSAs), 81 SACs, and 74 matched conventional adenocarcinomas (CCs) and were correlated with morphology, clinicopathological features, and MVD. In premalignant lesions, both HIF-1α and VEGF were expressed in the vast majority of SPs and NSAs. In CRCs, HIF-1α protein was also present in 77.8 % of SACs, while only 20.3 % of CCs were HIF-1α proficient. MVD was significantly higher in SACs, but the serrated morphology was the only significant predictor of MVD in CRC in multivariate analyses. HIF-1α protein is often stabilized in well-vascularized SACs, suggesting hypoxia - independent stabilization of HIF-1α. Moreover, HIF-1α stabilization did not associate with oncogenic activation of BRAF or KRAS or Von Hippel-Lindau (VHL) mutation. Prevalent HIF-1α expression in SAC and its precursors support the importance of HIF-1α -mediated pathways for the serrated route of colorectal carcinogenesis.
27421843	0	6	HIF-1α	T116,T123	C1528322
27421843	7	17	expression	T045	C1171362
27421843	27	46	microvessel density	T080	C3272839
27421843	78	104	serrated colorectal cancer	T191	C3272809
27421843	105	139	Serrated colorectal adenocarcinoma	T191	C3272809
27421843	141	144	SAC	T191	C3272809
27421843	151	166	morphologically	T082	C0543482
27421843	176	183	subtype	T185	C0449560
27421843	187	204	colorectal cancer	T191	C1527249
27421843	206	209	CRC	T191	C1527249
27421843	231	237	HIF-1α	T028	C1333897
27421843	238	253	mRNA expression	T045	C1515670
27421843	258	272	HIF-1α protein	T116,T123	C1528322
27421843	273	286	stabilization	T044	C1327386
27421843	344	350	HIF-1α	T116,T123	C1528322
27421843	351	369	protein expression	T045	C1171362
27421843	373	381	serrated	T191	C3272809
27421843	386	420	non-serrated colorectal carcinomas	T191	C0009402
27421843	422	426	CRCs	T191	C0009402
27421843	438	455	precursor lesions	T033	C0221198
27421843	464	480	association with	T080	C0332281
27421843	481	515	vascular endothelial growth factor	T116,T123	C1256770
27421843	517	521	VEGF	T116,T123	C1256770
27421843	527	548	microvascular density	T080	C3272839
27421843	550	553	MVD	T080	C3272839
27421843	556	562	HIF-1α	T116,T123	C1528322
27421843	567	571	VEGF	T116,T123	C1256770
27421843	572	583	expressions	T045	C1171362
27421843	600	621	immunohistochemically	T059	C1441616
27421843	629	644	serrated polyps	T190	C3266123
27421843	646	649	SPs	T190	C3266123
27421843	656	677	non-serrated adenomas	T191	C0001430
27421843	679	683	NSAs	T191	C0001430
27421843	689	693	SACs	T191	C3272809
27421843	710	738	conventional adenocarcinomas	T191	C0007112
27421843	740	743	CCs	T191	C0007112
27421843	754	764	correlated	T080	C1707520
27421843	770	780	morphology	T080	C0332437
27421843	782	810	clinicopathological features	T091	C0030667
27421843	816	819	MVD	T080	C3272839
27421843	824	844	premalignant lesions	T191	C0850639
27421843	851	857	HIF-1α	T116,T123	C1528322
27421843	862	866	VEGF	T116,T123	C1256770
27421843	872	881	expressed	T045	C1171362
27421843	906	909	SPs	T190	C3266123
27421843	914	918	NSAs	T191	C0001430
27421843	923	927	CRCs	T191	C1527249
27421843	929	943	HIF-1α protein	T116,T123	C1528322
27421843	974	978	SACs	T191	C3272809
27421843	1001	1004	CCs	T191	C0007112
27421843	1010	1016	HIF-1α	T116,T123	C1528322
27421843	1029	1032	MVD	T080	C3272839
27421843	1061	1065	SACs	T191	C3272809
27421843	1075	1083	serrated	T190	C3266123
27421843	1084	1094	morphology	T080	C0332437
27421843	1133	1136	MVD	T080	C3272839
27421843	1140	1143	CRC	T191	C1527249
27421843	1147	1168	multivariate analyses	T081	C0026777
27421843	1170	1184	HIF-1α protein	T116,T123	C1528322
27421843	1194	1204	stabilized	T061	C1293130
27421843	1208	1225	well-vascularized	T169	C0042382
27421843	1226	1230	SACs	T191	C3272809
27421843	1243	1250	hypoxia	T046	C0242184
27421843	1253	1278	independent stabilization	T061	C1293130
27421843	1282	1288	HIF-1α	T116,T123	C1528322
27421843	1300	1306	HIF-1α	T116,T123	C1528322
27421843	1307	1320	stabilization	T044	C1327386
27421843	1329	1343	associate with	T080	C0332281
27421843	1344	1353	oncogenic	T131	C0007090
27421843	1354	1364	activation	T045	C0017255
27421843	1368	1372	BRAF	T028	C0812241
27421843	1376	1380	KRAS	T028	C1537502
27421843	1384	1401	Von Hippel-Lindau	T028	C0694897
27421843	1403	1406	VHL	T028	C0694897
27421843	1408	1416	mutation	T045	C0596611
27421843	1428	1434	HIF-1α	T116,T123	C1528322
27421843	1435	1445	expression	T045	C1171362
27421843	1449	1452	SAC	T191	C3272809
27421843	1498	1504	HIF-1α	T116,T123	C1528322
27421843	1515	1523	pathways	T044	C1704259
27421843	1532	1575	serrated route of colorectal carcinogenesis	T191	C3272809